Silgan Holdings (SLGN) Tops Q3 EPS by 4c, Offers Guidance

Silgan Holdings (NASDAQ: SLGN) reported Q3 EPS of $1.27, $0.04 better than the analyst estimate of $1.23. Revenue for the quarter came in at $1.97 billion versus the consensus estimate of $1.85 billion.

GUIDANCE:

Silgan Holdings sees FY2022 EPS of $3.90-$4.00, versus the consensus of $3.95.

Silgan Holdings sees Q4 2022 EPS of $0.76-$0.86, versus the consensus of $0.87.

For earnings history and earnings-related data on Silgan Holdings (SLGN) click here.

You May Also Be Interested In

• Medtronic (MDT) Tops Q1 EPS by 6c, Beats on Revenue; Offers FY27 EPS Guidance
• Ascendis Pharma (ASND) PT Lowered to $304 at BofA Securities
• NIQ Global Intelligence Plc (NIQ) PT Raised to $25 at UBS